Anthony J. Cannon, MD, FACE

4.87 out of 5 (385 ratings, 134 reviews)
Ratings and Reviews

Departments

Cooper University Health Care Titles

  • Endocrinologist

Cooper Medical School of Rowan University Titles

  • Clinical Associate Professor of Medicine

Board Certifications

  • American Board of Internal Medicine (Internal Medicine)
  • American Board of Internal Medicine (Endocrinology, Diabetes, and Metabolism)

Professional Type

Cooper Care Alliance

NPI

1831259340

Office Locations

Cherry Hill
Cooper Care Alliance at Brace Road

1210 Brace Road
Cherry Hill , NJ 08034
Phone: 856.536.1515
Maps & Directions

Education & Training

Medical SchoolCornell University, New York, NY
InternshipInternal Medicine - Hartford Hospital, Hartford, CT
ResidencyInternal Medicine - Baystate Medical Center, Springfield, MA
FellowshipEndocrinology, Temple University Hospital, Philadelphia, PA

Memberships

  • American Diabetes Association
  • National Medical Association
  • Thyroid Club of South Jersey
  • American Association of Clinical Endocrinologists (AACE)

Awards and Honors

  • Recipient, American Diabetes Association Chair’s Citation Award - 2015
  • Fellow, American College of Endocrinology, FACE - 2012

Publications

Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S5-S13. doi: 10.18553/jmcp.2018.24.9-a.s5. PMID: 30156443.

Handelsman Y, Wyne K, Cannon A, Shannon M, Schneider D. Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S14-S29. doi: 10.18553/jmcp.2018.24.9-a.s14. Erratum in: J Manag Care Spec Pharm. 2018 Nov;24(11):1196a. PMID: 30156445.

Heile M, Wyne K, Billings LK, Cannon A, Handelsman Y, Shannon M. Cardiovascular Outcomes with Once-Weekly GLP-1 RAs: Clinical and Economic Implications. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S42-S52. doi: 10.18553/jmcp.2018.24.9-a.s42. PMID: 30156446.

Cannon A, Handelsman Y, Heile M, Shannon M. Burden of Illness in Type 2 Diabetes Mellitus. J Manag Care Spec Pharm. 2018 Sep;24(9-a Suppl):S5-S13. doi: 10.18553/jmcp.2018.24.9-a.s5. PMID: 30156443.

Shomali ME, Ørsted DD, Cannon AJ. Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials. Diabet Med. 2017 Feb;34(2):197-203. doi: 10.1111/dme.13185. Epub 2016 Aug 16. PMID: 27412701; PMCID: PMC5248619.

Ard J, Cannon A, Lewis CE, Lofton H, Vang Skjøth T, Stevenin B, Pi-Sunyer X. Efficacy and safety of liraglutide 3.0 mg for weight management are similar across races: subgroup analysis across the SCALE and phase II randomized trials. Diabetes Obes Metab. 2016 Apr;18(4):430-5. doi: 10.1111/dom.12632. Epub 2016 Feb 11. PMID: 26744025; PMCID: PMC6084344.

Peyrot M, Egede LE, Campos C, Cannon AJ, Funnell MM, Hsu WC, Ruggiero L, Siminerio LM, Stuckey HL. Ethnic differences in psychological outcomes among people with diabetes: USA results from the second Diabetes Attitudes, Wishes, and Needs (DAWN2) study. Curr Med Res Opin. 2014 Nov;30(11):2241-54. doi: 10.1185/03007995.2014.947023. Epub 2014 Aug 18. PMID: 25079662.

Mehta JM, Miller JL, Cannon AJ, Mardekian SK, Kenyon LC, Jabbour SA. Ovarian leydig cell hyperplasia: an unusual case of virilization in a postmenopausal woman. Case Rep Endocrinol. 2014;2014:762745. doi: 10.1155/2014/762745. Epub 2014 Jun 19. PMID: 25045549; PMCID: PMC4089940.

Cannon AJ. Delivering culturally competent care in clinical practice: a call to action. J Natl Med Assoc. 2012 Jan-Feb;104(1-2):104-7. doi: 10.1016/s0027-9684(15)33514-8. PMID: 22708254.

Ratings and Reviews

Ratings and reviews come from patient responses to health care provider-related questions on the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) Patient Experience Survey that Cooper sends to patients after outpatient office visits.  Learn more about our survey and how ratings are calculated >>

Overall Rating

4.87 out of 5 (385 ratings, 134 reviews)
Apr 12, 2023
All good
Apr 12, 2023
My husband and I absolutely adore Dr. Cannon. He is a pleasure and so informative. I always look forward to my appointment! Plus he always gets to the bottom of our problems.
Apr 12, 2023
Dr. Cannon was very good & assessed my condition with excellence. Concerned my questions & concerns.
Apr 12, 2023
They didn't need to contact me with my blood test results because I get them through the portal. Dr Cannon reviewed them with me during the [Date] 7 office visit.
Apr 12, 2023
I think that Dr. Cannon is an excellent physician.
Apr 12, 2023
My experience was excellent. I had an 8:40 am appointment. I arrived at 8:25 am and checked in. I just sat down to wait to be called back and was immediately called back by the Nurse Linda who asked me a lot of questions about my current medications and other personal information, then took my blood pressure, then I met with the doctor. I couldn't have asked for a better office visit, especially on a work day.
Apr 12, 2023
Visit with Dr. Cannon was amazing
Apr 12, 2023
My visits at this center are always pleasant staff and Dr Cannon are outstanding
Apr 12, 2023
Dr. Cannon is one of the finest physicians I have known. He has taken a particular interest in my cancer and treatment and has worked closely with my oncologist. Dr. Cannon's knowledge and concern has been very helpful in dealing with my disease.
Apr 12, 2023
Dr. Cannon is always very informative regarding the latest advancements concerning my condition (diabetes II).